ANI Pharmaceuticals, Inc. (ANIP)
81.57
+1.18
(+1.47%)
USD |
NASDAQ |
Dec 15, 16:00
81.57
0.00 (0.00%)
After-Hours: 19:23
ANI Pharmaceuticals Research and Development Expense (Annual): 44.58M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| CorMedix, Inc. | 3.942M |
| Arcutis Biotherapeutics, Inc. | 76.42M |
| Intellia Therapeutics, Inc. | 456.03M |
| Beam Therapeutics, Inc. | 367.56M |
| Halozyme Therapeutics, Inc. | 79.05M |